Pharmacovigilance reporting requirements

By choosing from the menu on the left you will find more information on how healthcare professionals or consumers can report suspected adverse drug reactions to the National Institute of Pharmacy (NIP), or you can familiarize yourself with the pharmacovigilance reporting obligations imposed on the marketing authorizations holder by the Competent Authority in Hungary (NIP).

Last updated: 2012.01.26 10:38
National Institute for Quality- and Organizational Development in Healthcare and Medicines
National Institute of Pharmacy
| H-1051 Budapest, Zrínyi u. 3. | Mail: 1372 P.O. Box: 450.
Tel: +36 1 88 69 -300 | Fax: +36 1 88 69-460 | Contact | Impressum | Sitemap | Copyright

Opening hours for docketing: Monday to Thursday: 8.30-12.00, Friday: 8.30-11.00